Detalhe da pesquisa
1.
Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real-life study.
Br J Haematol
; 199(1): 86-94, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906782
2.
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
Am J Hematol
; 97(12): E470-E473, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111658
3.
Prediction of major bleeding events in 1381 patients with essential thrombocythemia.
Int J Hematol
; 118(5): 589-595, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37660316
4.
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib.
Leukemia
; 35(2): 485-493, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33414483
5.
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.
Blood Cancer J
; 11(2): 21, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563901
6.
Second versus first wave of COVID-19 in patients with MPN.
Leukemia
; 36(3): 897-900, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064223
7.
Breakthrough infections in MPN-COVID vaccinated patients.
Blood Cancer J
; 12(11): 154, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379921
8.
Long-term follow-up of recovered MPN patients with COVID-19.
Blood Cancer J
; 11(6): 115, 2021 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135309
9.
Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).
Ann Hematol
; 89(2): 217-9, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19636554